HLIO:NYSEHelios Technologies, Inc. Analysis
Data as of 2026-05-19 - not real-time
$77.17
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Helios Technologies (HLIO) entered the quarter with a 23% year‑over‑year sales increase, beating analyst revenue forecasts. The company posted an EPS beat of 21%, reinforcing the bullish momentum seen in its price chart. Technical indicators are supportive: the price sits above the 20‑day (≈$70) and 50‑day (≈$68) SMAs, the MACD histogram is positive, and RSI sits at a healthy 64. Volume is on an upward trend, and the stock is trading near its $80 resistance level with a solid $65 support cushion. The Fear & Greed Index reads “Extreme Greed,” reflecting strong market sentiment.
However, the current market price of $77.17 exceeds the DCF‑derived fair value of $68.2 and trades at a trailing P/E of 42 versus an industry average of 29, suggesting the stock is overvalued. The dividend yield of 0.62% is backed by a modest 15% payout ratio and robust free cash flow, indicating sustainability. With a beta of 1.53 and 30‑day volatility above 50%, the equity carries elevated market risk. Nonetheless, its diversified global footprint and low debt‑to‑equity profile provide a buffer against sector downturns. Taken together, the fundamentals support a cautious but positive outlook, with upside potential modestly limited by valuation premiums.
However, the current market price of $77.17 exceeds the DCF‑derived fair value of $68.2 and trades at a trailing P/E of 42 versus an industry average of 29, suggesting the stock is overvalued. The dividend yield of 0.62% is backed by a modest 15% payout ratio and robust free cash flow, indicating sustainability. With a beta of 1.53 and 30‑day volatility above 50%, the equity carries elevated market risk. Nonetheless, its diversified global footprint and low debt‑to‑equity profile provide a buffer against sector downturns. Taken together, the fundamentals support a cautious but positive outlook, with upside potential modestly limited by valuation premiums.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish technical setup with price above key SMAs
- Upcoming earnings expected to confirm beat
- Proximity to resistance level limiting near‑term upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue and EPS growth trajectory
- Sustainable dividend and solid free cash flow
- Upside potential despite current premium valuation
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Diversified global exposure across industrial sectors
- Low payout ratio ensuring dividend durability
- Valuation compression risk offset by stable cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth16.80%
Profit Margin6.97%
P/E Ratio42.4
ROE6.69%
ROA4.37%
Debt/Equity39.33
P/B Ratio2.7
Op. Cash Flow$132.2M
Free Cash Flow$98.5M
Industry P/E29.5
Technical Analysis
TrendBullish
RSI63.8
Support$65.13
Resistance$80.00
MA 20$70.24
MA 50$68.15
MA 200$60.13
MACDBullish
VolumeIncreasing
Fear & Greed Index89.61
Valuation
Fair Value$68.17
Target Price$84.67
Upside/Downside9.71%
GradeOvervalued
TypeGrowth
Dividend Yield0.62%
Risk Assessment
Beta1.53
Volatility54.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.